Merit Medical Sys (MMSI) 24.49 $MMSI Henry Sche
Post# of 273257

Henry Schein Poised on Strategic Buyouts, Pricing Hurts
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 6:23AM CDT
On Sep 1, we issued an updated research report on Henry Schein, Inc. (HSIC).
DSCI: 4.72 (-0.12), ALGN: 95.78 (+2.02), HSIC: 164.29 (+1.31), MMSI: 24.49 (+0.09)
Merit Medical Systems Shares Up 28.2% Since SmarTrend's Buy Recommendation (MMSI)
Comtex SmarTrend(R) - Tue Aug 30, 1:09AM CDT
SmarTrend identified an Uptrend for Merit Medical Systems (NASDAQ:MMSI) on March 3rd, 2016 at $18.92. In approximately 6 months, Merit Medical Systems has returned 28.22% as of today's recent price of $24.26.
MMSI: 24.49 (+0.09)
Merit Medical to Present at Five Conferences
GlobeNewswire - Thu Aug 25, 8:25AM CDT
Wells Fargo - September 7
WFC: 50.55 (+0.12), MMSI: 24.49 (+0.09)
Research and Markets - US Transcatheter Embolization Particles Market Report 2016 Featuring Sirtex, BTG, Merit Medical Systems, Boston Scientific & Cook Medical
PR Newswire Europe - Wed Aug 24, 10:11AM CDT
DUBLIN, August 24, 2016 /PRNewswire/ --
BSX: 24.26 (-0.07), MMSI: 24.49 (+0.09)
Merit Medical (MMSI) Now a Strong Buy on Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 9:00AM CDT
On Aug 23, Zacks Investment Research raised Merit Medical Systems Inc. (MMSI) to a Zacks Rank #1 (Strong Buy) on estimate revisions.
HYH: 36.57 (+0.32), MASI: 59.90 (+0.47), CRY: 16.23 (+0.39), MMSI: 24.49 (+0.09)
Uptrend Call Working As Merit Medical Systems Stock Rises 25.5% (MMSI)
Comtex SmarTrend(R) - Mon Aug 22, 1:41PM CDT
SmarTrend identified an Uptrend for Merit Medical Systems (NASDAQ:MMSI) on March 3rd, 2016 at $18.92. In approximately 6 months, Merit Medical Systems has returned 25.48% as of today's recent price of $23.74.
MMSI: 24.49 (+0.09)
Endologix's Ovation Alto System Treats First Patients
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 8:00AM CDT
Endologix, recently announced the treatment of the first two abdominal aortic aneurysms patients with its Ovation Alto Abdominal Stent Graft System.
HYH: 36.57 (+0.32), ALGN: 95.78 (+2.02), ELGX: 12.22 (unch), MMSI: 24.49 (+0.09)
DENTSPLY (XRAY) Beats Q2 Earnings, FY16 View Maintained
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 2:47PM CDT
DENTSPLY SIRONA Inc. (XRAY) reported adjusted earnings of 76 cents per share in the second quarter of 2016, which beat the Zacks Consensus Estimate by 6 cents.
HYH: 36.57 (+0.32), MASI: 59.90 (+0.47), XRAY: 61.70 (+0.05), MMSI: 24.49 (+0.09)
PerkinElmer (PKI) Beats Q2 Earnings, FY16 View Maintained
Zacks Equity Research - Zacks Investment Research - Fri Aug 05, 2:32PM CDT
PerkinElmer Inc (PKI) reported second-quarter 2016 earnings of 67 cents per share, which beat the Zacks Consensus Estimate by a penny.
HYH: 36.57 (+0.32), MASI: 59.90 (+0.47), PKI: 53.46 (+0.20), MMSI: 24.49 (+0.09)
Becton, Dickinson (BDX) Tops Q3 Earnings, FY16 View Up
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 8:02AM CDT
Becton, Dickinson and Company (BDX), reported third-quarter fiscal 2016 earnings of $2.35 per share, which beat the Zacks Consensus Estimate by 16 cents.
HYH: 36.57 (+0.32), BDX: 177.32 (+0.30), ALGN: 95.78 (+2.02), MMSI: 24.49 (+0.09)
Research and Markets - United States Uterine Fibroid Embolization Devices Market Analysis 2016 Featuring Merit Medical Systems, Boston Scientific, BTG & Cook Medical
PR Newswire Europe - Wed Aug 03, 12:11PM CDT
DUBLIN, August 3, 2016 /PRNewswire/ --
BSX: 24.26 (-0.07), MMSI: 24.49 (+0.09)
Cardinal Health (CAH) Tops Q4 Earnings, '17 View Impressive
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 3:59PM CDT
Cardinal Health Inc. (CAH) reported fourth-quarter fiscal 2016 adjusted earnings of $1.14 per share, which beat the Zacks Consensus Estimate by a penny.
BCR: 221.21 (-0.29), ALGN: 95.78 (+2.02), CAH: 79.73 (+0.03), MMSI: 24.49 (+0.09)
Merit Medical to Present at Two Conferences
GlobeNewswire - Mon Aug 01, 8:25AM CDT
Canaccord Genuity - August 11
MMSI: 24.49 (+0.09)
Downgrade Alert for Merit Medical Systems (MMSI)
Comtex SmarTrend(R) - Fri Jul 29, 3:30AM CDT
Merit Medical Systems (NASDAQ:MMSI) was downgraded from Outperform to Market Perform at Barrington today. The stock closed yesterday at $23.47 on volume of 835,000 shares, above average daily volume of 248,000. Potential upside of 13.6% exists for Merit Medical Systems, based on a current level of $23.47 and analysts' average consensus price target of $26.67. The stock should discover initial support at its 200-day moving average (MA) of $20.17 and subsequent support at its 50-day MA of $18.88.
MMSI: 24.49 (+0.09)
Shares of MMSI Up 25.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 28, 1:51PM CDT
SmarTrend identified an Uptrend for Merit Medical Systems (NASDAQ:MMSI) on March 3rd, 2016 at $18.92. In approximately 5 months, Merit Medical Systems has returned 25.79% as of today's recent price of $23.80.
MMSI: 24.49 (+0.09)
Merit Medical Reports Sales Up 9.4% for the Quarter Ended June 30, 2016
GlobeNewswire - Wed Jul 27, 3:00PM CDT
-- Q2 revenue of $151.1 million ($151.7 million in constant currency), up 9.4% as reported, up 9.9% on a comparable, constant currency basis, over Q2 2015
MMSI: 24.49 (+0.09)
Merit Medical to Present at UBS Global Healthcare Conference
GlobeNewswire - Thu May 12, 8:00AM CDT
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it will participate at the UBS Global Healthcare Conference being held May 23-25 at the Grand Hyatt New York.
MMSI: 24.49 (+0.09)

